Physician profile
Rick Pellant
NPI 1154389187
$1,778.27
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.80 · 2020: $74.88 · 2021: $617 · 2022: $545 · 2023: $109 · 2024: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294 · Travel and Lodging: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.52 |
| Travel and Lodging | $201.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $551.99 | 2021-2024 | |
| Spr Therapeutics, INC | $352.78 | 2024 | Sprint Pns System |
| Abbott Laboratories | $212.73 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.63 | 2021-2022 | |
| Amgen INC. | $111.23 | 2020-2022 | |
| Redhill Biopharma INC. | $107.18 | 2020-2022 | |
| Pfizer INC. | $73.90 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $51.35 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.90 | 2022 | |
| Pacira Therapeutics, INC. | $33.40 | 2019-2021 | |
| Medtronic USA, INC. | $15.75 | 2019 | |
| Grt US Holding, INC. | $15.39 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.71 | 2021 | |
| Allergan, INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Pellant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.